Asked by: Stephen Doughty (Labour (Co-op) - Cardiff South and Penarth)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many facilities producing (a) generic and (b) speciality antibiotics there are in the UK.
Answered by Will Quince
The information requested is not collected centrally.
Asked by: Stephen Doughty (Labour (Co-op) - Cardiff South and Penarth)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will publish the (a) epidemiological data and (b) formula used by the Government to determine the designation of (a) Tanzania, (b) South Africa and (c) Malawi on the red list for mandatory hotel quarantine on arrival at the UK border; and if he will publish the (a) data and (b) formula used by the Government to determine the non-designation of (i) Kenya, (ii) Ethiopia and (iii) Nigeria on that list.
Answered by Jo Churchill
It has not proved possible to respond to the hon. Member in the time available before prorogation.
Asked by: Stephen Doughty (Labour (Co-op) - Cardiff South and Penarth)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will publish the (a) epidemiological data and (b) formula used by the Government to determine which countries are placed on the red list for mandatory hotel quarantine on arrival at the UK border.
Answered by Jo Churchill
It has not proved possible to respond to the hon. Member in the time available before prorogation.
Asked by: Stephen Doughty (Labour (Co-op) - Cardiff South and Penarth)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether the relative proportions of Pfizer-BioNTech and Oxford/AstraZeneca vaccine, as a proportion of total vaccine supply, being distributed (a) to regions within England and (b) to the devolved nations, are the same.
Answered by Nadhim Zahawi
The proportion of Pfizer-BioNTech to Oxford/AstraZeneca vaccines may vary between sites/regions due to logistical imperatives such as storage and wider national supply.
Asked by: Stephen Doughty (Labour (Co-op) - Cardiff South and Penarth)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how data on HIV is being taken into account in the new QCOVID population risk assessment tool following concerns raised by people living with HIV who have been asked to shield for the first time.
Answered by Jo Churchill
The COVID-19 population risk assessment, based on QCovid, uses a range of factors including age, sex registered at birth, ethnicity, postcode as an indicator of deprivation and body mass index alongside medical conditions to calculate a risk assessment score for each individual. Owing to small numbers, HIV has been included within the model in a broader group of conditions which includes other immunosuppressive disorders, such as sickle cell and immunodeficiency, to offer a representative level of potential risk. This is in keeping with emerging research evidence that suggests people living with HIV may be at increased risk from COVID-19.
If an individual living with HIV has received a letter advising them to shield, this will not be based solely on their HIV status, but on a wide range of factors. Any person living with HIV who is concerned can seek further advice from their general practitioner or specialist clinician.
Asked by: Stephen Doughty (Labour (Co-op) - Cardiff South and Penarth)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how people living with HIV will access the covid-19 vaccine in their priority grouping if they have not disclosed their HIV status to their local GP but are known at their HIV clinic.
Answered by Nadhim Zahawi
The new guidance means that people living with HIV in England can now choose to arrange their COVID-19 vaccine through specialist clinics, without notifying their general practitioner (GP).
We encourage everyone living with HIV to make their GP aware of their HIV diagnosis. Where that is not possible, HIV clinics should identify those who have not given permission to disclose their HIV status to their GP and refer individuals into local vaccination hubs.